Initially, LOXL1 and LOXL4 silencing by methylation were shown to have tumor-suppressive effects in human bladder cancer, while compensation experiments inhibited RAS-mediated ERK activation and reduced tumor-cell colony formation [49]. The gene discussed is LOXL1; the disease is neoplasm.